These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27264974)

  • 1. Antithrombotic Agents in the Management of Sepsis.
    Iqbal O; Tobu M; Hoppenstead D; Aziz S; Messmore H; Fareed J
    Turk J Haematol; 2002 Sep; 19(3):349-89. PubMed ID: 27264974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic agents in the treatment of severe sepsis.
    Iqbal O; Messmore H; Fareed J; Ahmad S; Hoppensteadt D; Hazar S; Tobu M; Aziz S; Wehrmacher W
    Expert Opin Emerg Drugs; 2002 May; 7(1):111-39. PubMed ID: 15989540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial.
    Opal S; Laterre PF; Abraham E; Francois B; Wittebole X; Lowry S; Dhainaut JF; Warren B; Dugernier T; Lopez A; Sanchez M; Demeyer I; Jauregui L; Lorente JA; McGee W; Reinhart K; Kljucar S; Souza S; Pribble J;
    Crit Care Med; 2004 Feb; 32(2):332-41. PubMed ID: 14758145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of antiplatelet agents in sepsis: a glimpse into the future.
    Akinosoglou K; Alexopoulos D
    Thromb Res; 2014 Feb; 133(2):131-8. PubMed ID: 24103487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators.
    Orfanos SE; Kotanidou A; Glynos C; Athanasiou C; Tsigkos S; Dimopoulou I; Sotiropoulou C; Zakynthinos S; Armaganidis A; Papapetropoulos A; Roussos C
    Crit Care Med; 2007 Jan; 35(1):199-206. PubMed ID: 17110873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of sepsis.
    Jacobi J
    Am J Health Syst Pharm; 2002 Feb; 59 Suppl 1():S3-8. PubMed ID: 11885412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytokine storm in the pathogenesis of multiple organ dysfunction syndrome associated with surgical insults].
    Aikawa N
    Nihon Geka Gakkai Zasshi; 1996 Sep; 97(9):771-7. PubMed ID: 8940690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure.
    Eisele B; Lamy M
    Semin Thromb Hemost; 1998; 24(1):71-80. PubMed ID: 9515782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sepsis and organ failure--its pathogenesis and treatment].
    Hanasawa K; Kodama M
    Nihon Geka Gakkai Zasshi; 1998 Aug; 99(8):523-7. PubMed ID: 9789288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation in patients with severe sepsis.
    Levi M; Poll Tv
    Semin Thromb Hemost; 2015 Feb; 41(1):9-15. PubMed ID: 25590524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.
    de Jonge E; van der Poll T; Kesecioglu J; Levi M
    Semin Thromb Hemost; 2001 Dec; 27(6):667-74. PubMed ID: 11740690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host responses in mediating sepsis and adult respiratory distress syndrome.
    Strieter RM; Lynch JP; Basha MA; Standiford TJ; Kasahara K; Kunkel SL
    Semin Respir Infect; 1990 Sep; 5(3):233-47. PubMed ID: 2123991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Other mediators of inflammation and sepsis].
    Lamy M; Deby-Dupont G; Damas P
    Rev Prat; 1993 Jan; 43(1):19-25. PubMed ID: 8469893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin replacement in patients with sepsis and septic shock.
    Giudici D; Baudo F; Palareti G; Ravizza A; Ridolfi L; D' Angelo A
    Haematologica; 1999 May; 84(5):452-60. PubMed ID: 10329925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiology of sepsis--will the basic research contribute to the improvement of outcome in clinical sepsis?].
    Karima R
    Masui; 2008 Mar; 57(3):278-93. PubMed ID: 18340996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coagulant response in sepsis and inflammation.
    Levi M
    Hamostaseologie; 2010 Jan; 30(1):10-2, 14-6. PubMed ID: 20162247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current management of septic shock.
    Russel JA
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular mechanisms in sepsis.
    Jean-Baptiste E
    J Intensive Care Med; 2007; 22(2):63-72. PubMed ID: 17456726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytokine-mediated biological response to severe infections in surgical patients].
    Aikawa N; Fujishima S; Shinozawa Y; Hori S
    Nihon Geka Gakkai Zasshi; 1996 Dec; 97(12):1054-9. PubMed ID: 9032781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.